Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
暂无分享,去创建一个
Pierre Grammond | Guillermo Izquierdo | Jeannette Lechner-Scott | Steve Simpson | Helmut Butzkueven | Guglielmo Lucchese | Maria Trojano | Freek Verheul | Bruce V. Taylor | Roberto Bergamaschi | Cavit Boz | J. Lechner-Scott | M. Slee | M. Trojano | F. Grand'Maison | H. Butzkueven | R. Bergamaschi | B. Taylor | G. Izquierdo | M. Amato | C. Boz | C. Oreja-Guevara | P. Duquette | E. Cristiano | R. Hupperts | S. Simpson | P. Grammond | V. van Pesch | G. Giuliani | F. Verheul | M. Fiol | M. Saladino | D. Paolicelli | P. Iaffaldano | C. Tortorella | G. Graziano | Maria Pia Amato | Vito Lepore | Celia Oreja-Guevara | Pierre Duquette | Damiano Paolicelli | V. Lepore | G. Lucchese | M. D’Onghia | V. Direnzo | Carla Tortorella | Raymond Hupperts | Giorgio Giuliani | Marcela Fiol | Mark Slee | Vincent Van Pesch | Edgardo Cristiano | Maria Laura Saladino | Francois Grand’Maison | Pietro Iaffaldano | Giusi Graziano | Mariangela D’Onghia | Vita Direnzo
[1] A. Sadovnick,et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[2] G. Giovannoni,et al. Smoking and Multiple Sclerosis: An Updated Meta-Analysis , 2011, PloS one.
[3] Yinshan Zhao,et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[4] T. Olsson,et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.
[5] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[6] A. Minagar,et al. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study , 2010, Multiple sclerosis.
[7] E. Celius,et al. Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades , 2009, Acta neurologica Scandinavica. Supplementum.
[8] C. Poser. Prevalence of multiple sclerosis , 1992, Annals of neurology.
[9] R. Marrie,et al. Changes in the ascertainment of multiple sclerosis , 2005, Neurology.
[10] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[11] Y. Itoyama,et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years , 2009, Multiple sclerosis.
[12] L. Wald,et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France , 2011, Neurology.
[13] C. Massilamany,et al. Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139–151 in SJL mice , 2011, Journal of Neuroimmunology.
[14] M. Schumacher,et al. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. , 2011, Maturitas.
[15] G. Giovannoni,et al. An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis , 2010, PloS one.
[16] L. Kappos,et al. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis , 2006, Multiple sclerosis.
[17] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.
[18] T. Riise,et al. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway , 2009, Multiple sclerosis.
[19] M. Horsburgh,et al. AUCKLAND DISTRICT HEALTH BOARD , 2003 .
[20] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[21] B. Hemmer,et al. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. , 2011, Autoimmunity reviews.
[22] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[23] P. Sørensen,et al. The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.
[24] H. Brønnum-Hansen,et al. Prevalence of multiple sclerosis in Denmark 1950—2005 , 2010, Multiple sclerosis.
[25] E. Willoughby,et al. MS prevalence in New Zealand, an ethnically and latitudinally diverse country , 2010, Multiple sclerosis.
[26] A. Ponsonby,et al. Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009 , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[27] T. Dwyer,et al. Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.
[28] M. Amini,et al. Prevalence of Vitamin D Deficiency in Isfahani High School Students in 2004 , 2005, Hormone Research in Paediatrics.
[29] Barrie J Hurwitz,et al. Registry studies of long-term multiple sclerosis outcomes , 2011, Neurology.
[30] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[31] F. Guillemin,et al. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France , 2007, Multiple sclerosis.
[32] Justin A. Spanier,et al. Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression1 , 2009, The Journal of Immunology.
[33] J. Salzer. Environmental risk factors for multiple sclerosis , 2013 .
[34] W. James Gauderman,et al. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins , 2007, Neurology.
[35] M. Sahraian,et al. Multiple Sclerosis in Iran: A Demographic Study of 8,000 Patients and Changes over Time , 2010, European Neurology.
[36] W. Valdar,et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.
[37] A. Ascherio,et al. Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence. , 2011, Annals of Epidemiology.
[38] J. Correale,et al. Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.
[39] A. Sadovnick,et al. MHC transmission , 2011, Neurology.
[40] C. Polman,et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women , 2009, Multiple sclerosis.
[41] T. Sarpel,et al. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. , 2001, Journal of women's health & gender-based medicine.
[42] J. Byrnes,et al. Sex ratio of multiple sclerosis and clinical phenotype , 2010, European journal of neurology.
[43] J. Correale,et al. Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects , 2010, The Journal of Immunology.
[44] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.
[45] J. Knight,et al. Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.
[46] G. Ebers,et al. Relationship of UV exposure to prevalence of multiple sclerosis in England , 2011, Neurology.
[47] A. Sadovnick,et al. European Charcot Foundation Lecture: The natural history of multiple sclerosis and gender , 2009, Journal of the Neurological Sciences.
[48] C. Bever,et al. Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis , 2010, Neuroepidemiology.
[49] M. Hernán,et al. Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.